Skin made 30 years younger with a new technique
Researchers have developed a way to reverse the ageing process in skin cells, turning back the biological clock by about 30 years. De-ageing cells has become increasingly common in the last decade, with researchers reprogramming multiple mouse, rat and human cell types. But never before have cells been de-aged by so many years and still retained their specific type and function.
The method, developed by Diljeet Gill, a postdoctoral candidate at the Babraham Institute in Cambridge, and his colleagues has been dubbed ‘maturation phase transient reprogramming’.
The researchers applied this technique to fibroblasts, a common type of skin cell, from three middle-aged donors who averaged about 50 years old, then compared them to younger cells from donors aged 20 to 22.
The researchers found that the middle-aged cells were similar to the younger cells, both chemically and genetically. When explored further, the team even noticed that the technique had affected genes related to age-related diseases, like Alzheimer’s and
cataracts. In addition, Gill and his colleagues looked at the behaviour of the fibroblasts to determine if they could also act like younger skin cells. When they wounded a layer of the cells, they found that the rejuvenated cells quickly moved to fill the gap in the same way that younger cells behave when healing wounds.
This study is not the first to de-age skin cells. That title goes to Nobel Prize in Physiology or Medicine winner Shinya Yamanaka, who genetically reprogrammed mouse skin cells and turned them into so-called induced pluripotent stem cells, or IPSCS, back in 2006. These IPSCS resemble cells in early development and have the potential to form any cell type in the body. The new research is based in part on Yamanaka’s method, but there are some key differences. Yamanaka’s method takes around 50 days and completely reprograms cells to the biological age of an embryo.
Gill’s method takes just 13 days and only partially reprograms cells so that they still retain their identity – in this case, the identity of skin cells.
While turning mature cells into stem cells is great for research, the complete reprogramming process is not ideal for therapeutics. Completely reprogrammed cells lose their identities and specialised cell functions. And when implanted into the body, these fully reprogrammed cells can become cancerous. In contrast, partially reprogrammed cells, like the skin cells in Gill’s research, become biologically younger and retain specialised cell functions, though they could still potentially pose a risk of cancer.
“Our results represent a big step forward in our understanding of cell reprogramming,”
Gill said. “We have proved that cells can be rejuvenated without losing their function and that rejuvenation looks to restore some function to old cells.” While their work is very promising, Gill and his colleagues acknowledge that their paper is a proof-ofconcept study. The authors said that they’re not sure how fibroblasts from younger or older individuals would react to the new reprogramming method or if cells from people of very different ages would always de-age by 30 years.